Cargando…
Spontaneous Diabetes in Hemizygous Human Amylin Transgenic Mice That Developed Neither Islet Amyloid nor Peripheral Insulin Resistance
OBJECTIVES—We sought to 1) Determine whether soluble-misfolded amylin or insoluble-fibrillar amylin may cause or result from diabetes in human amylin transgenic mice and 2) determine the role, if any, that insulin resistance might play in these processes. RESEARCH DESIGN AND METHODS—We characterized...
Autores principales: | Wong, Winifred P.S., Scott, David W., Chuang, Chia-Lin, Zhang, Shaoping, Liu, Hong, Ferreira, Athena, Saafi, Etuate L., Choong, Yee Soon, Cooper, Garth J.S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551684/ https://www.ncbi.nlm.nih.gov/pubmed/18633116 http://dx.doi.org/10.2337/db06-1755 |
Ejemplares similares
-
Tetracycline Treatment Retards the Onset and Slows the Progression of Diabetes in Human Amylin/Islet Amyloid Polypeptide Transgenic Mice
por: Aitken, Jacqueline F., et al.
Publicado: (2010) -
Small Interfering RNA–Mediated Suppression of Proislet Amyloid Polypeptide Expression Inhibits Islet Amyloid Formation and Enhances Survival of Human Islets in Culture
por: Marzban, Lucy, et al.
Publicado: (2008) -
Phenotypic Characterization of MIP-CreERT(1Lphi) Mice With Transgene-Driven Islet Expression of Human Growth Hormone
por: Oropeza, Daniel, et al.
Publicado: (2015) -
miR-33a Modulates ABCA1 Expression, Cholesterol Accumulation, and Insulin Secretion in Pancreatic Islets
por: Wijesekara, Nadeeja, et al.
Publicado: (2012) -
Neither Angel nor Beast
por: Coleman, Francis
Publicado: (2013)